↓ Skip to main content

Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice

Overview of attention for article published in BMC Cancer, February 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
95 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice
Published in
BMC Cancer, February 2019
DOI 10.1186/s12885-019-5354-5
Pubmed ID
Authors

Derek Weycker, Mark Hatfield, Aaron Grossman, Ahuva Hanau, Alex Lonshteyn, Anjali Sharma, David Chandler

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 95 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 13%
Researcher 11 12%
Student > Master 10 11%
Student > Ph. D. Student 8 8%
Other 7 7%
Other 13 14%
Unknown 34 36%
Readers by discipline Count As %
Medicine and Dentistry 27 28%
Pharmacology, Toxicology and Pharmaceutical Science 12 13%
Nursing and Health Professions 7 7%
Biochemistry, Genetics and Molecular Biology 5 5%
Agricultural and Biological Sciences 3 3%
Other 8 8%
Unknown 33 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2022.
All research outputs
#3,009,134
of 23,221,875 outputs
Outputs from BMC Cancer
#661
of 8,419 outputs
Outputs of similar age
#75,831
of 448,543 outputs
Outputs of similar age from BMC Cancer
#20
of 164 outputs
Altmetric has tracked 23,221,875 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,419 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,543 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 164 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.